tak 779 has been researched along with cmpd 167 in 1 studies
| Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (cmpd 167) | Trials (cmpd 167) | Recent Studies (post-2010) (cmpd 167) |
|---|---|---|---|---|---|
| 118 | 1 | 35 | 12 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Q; Huang, X; Shattock, RJ | 1 |
1 other study(ies) available for tak 779 and cmpd 167
| Article | Year |
|---|---|
C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors.
Topics: Amides; Antibodies, Monoclonal; CCR5 Receptor Antagonists; Cyclohexanes; env Gene Products, Human Immunodeficiency Virus; HIV Fusion Inhibitors; HIV-1; Humans; Maraviroc; Protein Binding; Pyrazoles; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, HIV; Triazoles; Valine; Virus Internalization | 2010 |